[Persistent influenza virus infection in a patient treated with alemtuzumab]

Med Mal Infect. 2010 Nov;40(11):657-9. doi: 10.1016/j.medmal.2010.03.001. Epub 2010 Jul 16.
[Article in French]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Chronic Disease
  • Humans
  • Influenza A Virus, H3N2 Subtype*
  • Influenza, Human / etiology*
  • Male
  • Middle Aged
  • Red-Cell Aplasia, Pure / chemically induced*
  • Red-Cell Aplasia, Pure / complications*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab